Cancer immunity Viral antigens

NF-kB (nuclear factor kappa-light-chain-enhancer of activated B-cells) is a protein complex that acts as a transcription factor. It is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, UV radiation, oxidised lipoproteins and bacterial or viral antigens. It plays a key role in regulating the immune response to infection. Consistent with this role, incorrect regulation of NF-/cB has been linked to cancer, inflammatory and automunune disease, septic shock, viral infection and improper immune development. 

T cells are further divided into three primary classes helper T cells (T-H cells), cytotoxic T cells (ctx T cells), and T suppressor T cells. T-H cells augment B cell responses to bacterial antigens. Cytotoxic T cells attack viral antigens and some early cancer cells. And suppressor T cells halt immune cell functions, allowing the body to rest. 

Biological products were developed traditionally, before recombinant proteins, as extracts or derivatives of the actual protein from the human body or nature. This approach continues today and Table 15 lists 18 such products, mostly blood derivatives for therapeutic use. Albumin is obtained for cardiovascular volume conditions. A fish protein is harvested for osteoporosis. Igs extracted from blood are available for immunodeficiency conditions, viral infections (hepatitis-B and vaccinia), hemolytic anemia in newborns, and idiopathic thrombocytopenic purpurea. Antihemophilic products are still derived from blood. An antiglobulin is produced for kidney transplant rejection. A collagen product and two botulinum toxin products are used for various facial wrinkle problems and cervical dystonia. A bacterial antigen is formulated to enhance immunity to treat a cancer. 

---